For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
How are we doing? Seeking GP feedback on medicines funding
+Print Archive
How it works
How are we doing? Seeking GP feedback on medicines funding
Wednesday 11 September 2024, 02:00 AM

Pharmac has recently updated how doctors can provide opinions on medicine funding decisions [Image: Anna Semenchenko on iStock]
Geraldine MacGibbon explains Pharmac’s consultation process for medicine funding proposals and why input from GPs is crucial
It is important for us to hear directly from doctors who are treating patients with the health condition for which we’re looking to fund a medicine
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.